Developped in the first instance by and for drug users by inhalation, KitBase® is a collaborative effort of seven Parisian associations which are in daily contact with users. To concretize their project, these associations called Terpan Prévention which was immediately favourable and took part in the project.
After several months of development and trials, KitBase® was finalized on 2014 and is now available on the market through associations. It allows to reduce significantly the risk of tranmission of blood-borne infections such as HIV and Hepatitis C.
This collaborativ project fits completely in Terpan Prévention way of thinking who considers prevention as a daily concern.